Richard K. Conley

Filings by Richard K. Conley span 2 companies, the busiest being Sonoma Pharmaceuticals, Inc. and Pulmatrix, Inc. Between 30 January 2007 and 11 May 2014, the trades on record add up to 8 filings.

On the open market, the record shows 1 purchase worth €7,811 and 2 sales worth €47k. On balance, insiders were net sellers of €40k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 3 share grants and 1 option exercise.

The newest entry dates from 13 May 2014: a share grant, in Pulmatrix, Inc. The last insider purchase was made public on 24 September 2007, 6,986 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.